HAEMONETICS CORP Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Haemonetics Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q3 2024.
  • Haemonetics Corp Income Tax Expense (Benefit) for the quarter ending September 28, 2024 was $10.9M, a 37.2% increase year-over-year.
  • Haemonetics Corp Income Tax Expense (Benefit) for the twelve months ending September 28, 2024 was $35M, a 13.1% increase year-over-year.
  • Haemonetics Corp annual Income Tax Expense (Benefit) for 2023 was $34.3M, a 31.9% increase from 2022.
  • Haemonetics Corp annual Income Tax Expense (Benefit) for 2022 was $26M, a 28.4% increase from 2021.
  • Haemonetics Corp annual Income Tax Expense (Benefit) for 2021 was $20.3M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $35M $10.9M +$2.95M +37.2% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-07
Q2 2024 $32.1M $8.34M -$2.21M -20.9% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-08
Q1 2024 $34.3M $3.05M -$196K -6.04% Dec 31, 2023 Mar 30, 2024 10-K 2024-05-20
Q4 2023 $34.5M $12.8M +$3.51M +37.8% Oct 1, 2023 Dec 30, 2023 10-Q 2024-02-08
Q3 2023 $31M $7.92M +$62K +0.79% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $30.9M $10.5M +$4.93M +87.8% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-08
Q1 2023 $26M $3.24M -$2.34M -41.9% Jan 1, 2023 Apr 1, 2023 10-K 2024-05-20
Q4 2022 $28.3M $9.28M +$1.12M +13.8% Oct 2, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $27.2M $7.86M +$2.8M +55.2% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-02
Q2 2022 $24.4M $5.62M +$4.17M +288% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 $20.3M $5.59M +$21.9M Jan 2, 2022 Apr 2, 2022 10-K 2024-05-20
Q4 2021 -$1.69M $8.16M +$2.66M +48.5% Oct 3, 2021 Jan 1, 2022 10-Q 2023-02-07
Q3 2021 -$4.35M $5.07M -$1.79M -26.1% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-08
Q2 2021 -$2.56M $1.45M +$3.99M Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-10
Q1 2021 -$6.56M -$16.4M -$20.7M -477% Dec 27, 2020 Apr 3, 2021 10-K 2023-05-22
Q4 2020 $14.1M $5.49M -$2.44M -30.8% Sep 27, 2020 Dec 26, 2020 10-Q 2022-02-08
Q3 2020 $16.6M $6.86M -$747K -9.83% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-09
Q2 2020 $17.3M -$2.55M +$6.7M +72.5% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $10.6M $4.34M +$3.35M +341% Dec 29, 2019 Mar 28, 2020 10-K 2022-05-25
Q4 2019 $7.27M $7.93M +$749K +10.4% Sep 29, 2019 Dec 28, 2019 10-Q 2021-02-02
Q3 2019 $6.53M $7.6M +$3.29M +76.3% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-04
Q2 2019 $3.23M -$9.25M -$15.4M -251% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-04
Q1 2019 $18.6M $984K -$448K -31.3% Dec 30, 2018 Mar 30, 2019 10-K 2021-05-26
Q4 2018 $19.1M $7.19M +$431K +6.38% Sep 30, 2018 Dec 29, 2018 10-Q 2020-02-04
Q3 2018 $18.6M $4.31M +$1.55M +56.3% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-01
Q2 2018 $17.1M $6.13M +$3.02M +96.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $14.1M $1.43M +$9.48M Dec 31, 2017 Mar 31, 2018 10-K 2020-05-20
Q4 2017 $4.58M $6.75M +$3.21M +90.6% Oct 1, 2017 Dec 30, 2017 10-Q 2019-02-05
Q3 2017 $1.37M $2.76M -$248K -8.25% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $1.62M $3.12M +$2.83M +982% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-07
Q1 2017 -$1.21M -$8.05M -$8.51M -1823% Jan 1, 2017 Apr 1, 2017 10-K 2019-05-22
Q4 2016 $7.31M $3.54M +$7.42M Oct 2, 2016 Dec 31, 2016 10-Q 2018-02-06
Q3 2016 -$116K $3.01M -$703K -18.9% Jul 3, 2016 Oct 1, 2016 10-Q 2017-11-07
Q2 2016 $587K $288K -$1.58M -84.5% Apr 3, 2016 Jul 2, 2016 10-Q 2017-08-07
Q1 2016 $2.16M $467K -$12.1M -96.3% Dec 27, 2015 Apr 2, 2016 10-K 2018-05-23
Q4 2015 $14.3M -$3.88M -$3.84M -10672% Sep 27, 2015 Dec 26, 2015 10-Q 2017-02-06
Q3 2015 $18.1M $3.71M +$1.44M +63.1% Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-07
Q2 2015 $16.7M $1.86M +$2.42M Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-01
Q1 2015 $14.3M $12.6M +$13M Dec 28, 2014 Mar 28, 2015 10-K 2017-05-24
Q4 2014 $1.25M -$36K +$1.25M +97.2% Sep 28, 2014 Dec 27, 2014 10-Q 2016-02-02
Q3 2014 $3K $2.28M -$2.07M -47.6% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-04
Q2 2014 $2.07M -$560K +$815K +59.3% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-30
Q1 2014 $1.25M -$430K -$2.56M -120% Dec 29, 2013 Mar 29, 2014 10-K 2016-06-01
Q4 2013 $3.81M -$1.28M -$4.58M -139% Sep 29, 2013 Dec 28, 2013 10-Q 2015-02-05
Q3 2013 $8.39M $4.34M +$2.3M +112% Jun 30, 2013 Sep 28, 2013 10-Q 2014-11-04
Q2 2013 $6.09M -$1.38M -$5M -138% Mar 31, 2013 Jun 29, 2013 10-Q 2014-07-31
Q1 2013 $11.1M $2.13M -$1.4M -39.7% Dec 30, 2012 Mar 30, 2013 10-K 2015-05-22
Q4 2012 $12.5M $3.3M -$3.91M -54.2% Sep 30, 2012 Dec 29, 2012 10-Q 2014-01-30
Q3 2012 $16.4M $2.04M -$3.09M -60.2% Jul 1, 2012 Sep 29, 2012 10-Q 2013-10-30
Q2 2012 $19.5M $3.63M -$3.12M -46.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $22.6M $3.52M -$4.06M -53.5% Jan 1, 2012 Mar 31, 2012 10-K 2014-05-22
Q4 2011 $26.7M $7.21M -$1.03M -12.5% Oct 2, 2011 Dec 31, 2011 10-Q 2013-02-01
Q3 2011 $27.7M $5.13M -$2.69M -34.4% Jul 3, 2011 Oct 1, 2011 10-Q 2012-11-07
Q2 2011 $30.4M $6.75M +$289K +4.48% Apr 3, 2011 Jul 2, 2011 10-Q 2012-08-08
Q1 2011 $30.1M $7.58M Jan 2, 2011 Apr 2, 2011 10-K 2013-05-20
Q4 2010 $8.24M Oct 3, 2010 Jan 1, 2011 10-Q 2012-02-06
Q3 2010 $7.82M Jul 4, 2010 Oct 2, 2010 10-Q 2011-11-03
Q2 2010 $6.46M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.